Longer-term follow-up of patients (pts) receiving prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (CRS) in the phase 1/2 MajesTEC-1 study of teclistamab in relapsed/refractory multiple myeloma (RRMM).

被引：0
|
作者：
van de Donk, Niels W. C. J.
Garfall, Alfred L.
Benboubker, Lotfi
Uttervall, Katarina
Groen, Kaz
Rosinol, Laura
Matous, Jeffrey V.
Vishwamitra, Deeksha
Hodin, Caroline
Stephenson, Tara
Qi, Keqin
Zuppa, Athena
Chastain, Katherine
Mateos, Maria-Victoria
机构：
[1] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands
[2] Penn Med Abramson Canc Ctr, Philadelphia, PA USA
[3] Ctr Hosp Reg Univ, Hop Bretonneau, Tours, France
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Vrije Univ, Amsterdam Univ Med Ctr, Amsterdam, Netherlands
[6] Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain
[7] Colorado Blood Canc Inst, Denver, CO USA
[8] Sarah Cannon Res Inst, Denver, CO USA
[9] Johnson & Johnson Innovat Med, Spring House, PA USA
[10] Johnson & Johnson Innovat Med, Antwerp, Belgium
[11] Johnson & Johnson Innovat Med, Titusville, NJ USA
[12] Johnson & Johnson Innovat Med, Raritan, NJ USA
[13] Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, Ctr Invest Canc IBMCC USAL, CSIC, Salamanca, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7517
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Longer-Term Follow-up of Patients Receiving Prophylactic Tocilizumab for the Reduction of Cytokine Release Syndrome (CRS) in the Phase 1/2 MajesTEC-1 Study of Teclistamab in Relapsed/Refractory Multiple Myeloma (RRMM)
    van de Donk, Niels W. C. J.
    Garfall, Alfred L.
    Benboubker, Lotfi
    Uttervall, Katarina
    Groen, Kaz
    Rosinol, Laura
    Matous, Jeffrey V.
    Vishwamitra, Deeksha
    Hodin, Caroline
    Stephenson, Tara
    Qi, Keqin
    Zuppa, Athena
    Chastain, Katherine
    Mateos, Maria-Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S549 - S549
  • [2] Longer-Term Follow-Up of Patients Receiving Prophylactic Tocilizumab for Cytokine Release Syndrome in the Phase 1/2 MajesTEC-1 Study of Teclistamab in Relapsed/Refractory Multiple Myeloma
    Rosinol, Laura
    Garfall, Alfred
    Benboubker, Lotfi
    Uttervall, Katarina
    Groen, Kaz
    van de Donk, Niels
    Matous, Jeffrey
    Vishwamitra, Deeksha
    Hodin, Caroline
    Stephenson, Tara
    Qi, Keqin
    Zuppa, Athena
    Chastain, Katherine
    Mateos Manteca, Maria-Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S84 - S85
  • [3] Long-Term Follow-Up From the Phase 1/2 MajesTEC-1 Trial of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
    Garfall, Alfred L.
    Nooka, Ajay K.
    van de Donk, Niels W. C. J.
    Moreau, Philippe
    Bhutani, Manisha
    Oriol, Albert
    Martin, Thomas G.
    Rosinol, Laura
    Mateos, Maria-Victoria
    Bahlis, Nizar
    Popat, Rakesh
    Besemer, Britta
    Martinez-Lopez, Joaquin
    Krishnan, Amrita Y.
    Delforge, Michel
    Huang, Lin
    Vishwamitra, Deeksha
    Stephenson, Tara
    Chastain, Katherine
    Sidana, Surbhi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S548 - S548
  • [4] Evaluation of prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (CRS) to inform the management of patients (pts) treated with teclistamab in MajesTEC-1.
    van de Donk, Niels W. C. J.
    Garfall, Alfred L.
    Benboubker, Lotfi
    Uttervall, Katarina
    Groen, Kaz
    Rosinol, Laura
    Hodin, Caroline
    Stephenson, Tara
    Trancucci, Danielle
    Perales-Puchalt, Alfredo
    Kobos, Rachel
    Banerjee, Arnob
    Mateos, Maria-Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] MANAGING CYTOKINE RELEASE SYNDROME IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXPERIENCE WITH TECLISTAMAB IN THE MAJESTEC-1 STUDY
    Catamero, Donna
    Blazquez, Patricia
    Shenoy, Samantha
    Chastain, Katherine
    Kruyswijk, Sandy
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [6] Managing cytokine release syndrome in relapsed/refractory multiple myeloma: experience with teclistamab in the MajesTEC-1 study
    Catamero, Donna
    Benito, Patricia Blazquez
    Shenoy, Samantha
    Chastain, Katherine
    Kruyswijk, Sandy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S315 - S316
  • [7] Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma
    Garfall, Alfred L.
    Nooka, Ajay K.
    van de Donk, Niels W. C. J.
    Moreau, Philippe
    Bhutani, Manisha
    Oriol, Albert
    Martin, Thomas G.
    Rosinol, Laura
    Mateos, Maria-Victoria
    Bahlis, Nizar J.
    Popat, Rakesh
    Besemer, Britta
    Martinez-Lopez, Joaquin
    Krishnan, Amrita Y.
    Delforge, Michel
    Huang, Lin
    Vishwamitra, Deeksha
    Stephenson, Tara
    Chastain, Katherine
    Sidana, Surbhi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Long-Term Follow-Up From the Phase 1/2 MajesTEC-1 Trial of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma
    Popat, Rakesh
    Nooka, Ajay
    van de donk, Niels
    Moreau, Philippe
    Bhutani, Manisha
    Oriol, Albert
    Martin, Thomas
    Rosinol, Laura
    Mateos Manteca, Maria-Victoria
    Bahlis, Nizar J.
    Garfall, Alfred
    Besemer, Britta
    Martinez-Lopez, Joaquin
    Krishnan, Amrita
    Delforge, Michel
    Huang, Lin
    Vishwamitra, Deeksha
    Stephenson, Tara
    Chastain, Katherine
    Sidana, Surbhi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S80 - S80
  • [9] Nursing Considerations for Cytokine Release Syndrome in Relapsed/ Refractory Multiple Myeloma: Experience with Teclistamab from the MajesTEC-1 Study
    Catamero, Donna
    Benito, Patricia Blazquez
    Shenoy, Samantha
    Doyle, Margaret
    Fowler, Jessica
    Kobos, Rachel
    Banerjee, Arnob
    Kruyswijk, Sandy
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (03)
  • [10] Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma
    Martin, Thomas G.
    Mateos, Maria Victoria
    Nooka, Ajay
    Banerjee, Arnob
    Kobos, Rachel
    Pei, Lixia
    Qi, Ming
    Verona, Raluca
    Doyle, Margaret
    Smit, Jennifer
    Sun, Weili
    Trancucci, Danielle
    Uhlar, Clarissa
    van de Donk, Niels W. C. J.
    Rodriguez, Cesar
    CANCER, 2023, 129 (13) : 2035 - 2046
12345